|
1
|
Bowlus CL, Levy C, Hirschfield GM. Reply to: "Seladelpar in patients with primary biliary cholangitis: Need for a closer look!". J Hepatol 2022; 77:1452-1453. [PMID: 35977610 DOI: 10.1016/j.jhep.2022.07.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Revised: 07/18/2022] [Accepted: 07/20/2022] [Indexed: 12/04/2022]
Affiliation(s)
- Christopher L Bowlus
- Department of Internal Medicine, University of California, Davis, Davis, California, United States.
| | - Cynthia Levy
- University of Miami Miller School of Medicine, Miami, Florida, United States
| | - Gideon M Hirschfield
- Toronto Centre for Liver Disease, University Health Network and Department of Medicine, University of Toronto, Toronto, Ontario, Canada
| |
Collapse
|